To learn about the possibilities of modern proton therapy, the Georgian Minister of Education and Research, Prof. Mikheil Chkhenkeli, visited the National Center for Radiation Research in Oncology - OncoRay on May 4, 2022. During the visit, the Georgian politician and the Board of Directors of Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Prof. Sebastian M. Schmidt and Dr. Diana Stiller, signed an official Memorandum of Understanding (MoU), which lays the foundation for the research center's inclusion in the "Georgian-German Science Bridge" (GGSB).
"Especially at the present time, it becomes clear how important cooperations with reliable partners are, from which both sides benefit," assesses the Scientific Director of the HZDR, Sebastian M. Schmidt. "The Georgian-German Science Bridge has already existed for more than 20 years and has produced numerous successes in education, research and knowledge transfer. I am extremely pleased that our Georgian partners now want to include the HZDR, which underlines the special importance of our center as a bridge to the Eastern European research area."
In addition to Forschungszentrum Jülich on the German side, the GGSB includes a consortium of Georgian universities and the state research organization Shota Rustaveli National Science Foundation. To explore possible collaborations, scientists* from the Eastern European institutions and the HZDR will meet for a first workshop on May 5, 2022. As the partners have stated in the memorandum of understanding, they see great potential for future cooperation especially in the fields of proton therapy, fluid dynamics, radiation physics, radiooncology and renewable energies.
In addition, the Dresden experts intend to contribute their scientific and technical expertise to the construction and operation of a cyclotron at the first Georgian Center for Proton Therapy at Kutaisi International University. Joint exchange programs for bachelor's and master's students as well as for doctoral students are to lay the foundation for joint applications to European Union funding programs such as the Marie Skłodowska-Curie Actions.
Link to original article.